These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23211626)

  • 1. Evaluation of long-term transgene expression in piggyBac-modified human T lymphocytes.
    Nakazawa Y; Saha S; Galvan DL; Huye L; Rollins L; Rooney CM; Wilson MH
    J Immunother; 2013 Jan; 36(1):3-10. PubMed ID: 23211626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. piggyBac transposon system modification of primary human T cells.
    Saha S; Nakazawa Y; Huye LE; Doherty JE; Galvan DL; Rooney CM; Wilson MH
    J Vis Exp; 2012 Nov; (69):e4235. PubMed ID: 23149543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of the PiggyBac transposon system for the sustained genetic modification of human T lymphocytes.
    Nakazawa Y; Huye LE; Dotti G; Foster AE; Vera JF; Manuri PR; June CH; Rooney CM; Wilson MH
    J Immunother; 2009 Oct; 32(8):826-36. PubMed ID: 19752751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of trichostatin A and 5-Aza-2'-deoxycytidine on transgene reactivation and epigenetic modification in transgenic pig fibroblast cells.
    Kong Q; Wu M; Wang Z; Zhang X; Li L; Liu X; Mu Y; Liu Z
    Mol Cell Biochem; 2011 Sep; 355(1-2):157-65. PubMed ID: 21541675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system.
    Sumiyoshi T; Holt NG; Hollis RP; Ge S; Cannon PM; Crooks GM; Kohn DB
    Hum Gene Ther; 2009 Dec; 20(12):1607-26. PubMed ID: 19689196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Position effect variegation and epigenetic modification of a transgene in a pig model.
    Yin Z; Kong QR; Zhao ZP; Wu ML; Mu YS; Hu K; Liu ZH
    Genet Mol Res; 2012 Feb; 11(1):355-69. PubMed ID: 22370938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the potential for undesired genomic effects of the piggyBac transposon system in human cells.
    Saha S; Woodard LE; Charron EM; Welch RC; Rooney CM; Wilson MH
    Nucleic Acids Res; 2015 Feb; 43(3):1770-82. PubMed ID: 25605795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An adaptable system for improving transposon-based gene expression in vivo via transient transgene repression.
    Doherty JE; Woodard LE; Bear AS; Foster AE; Wilson MH
    FASEB J; 2013 Sep; 27(9):3753-62. PubMed ID: 23752206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PiggyBac-engineered T cells expressing a glypican-3-specific chimeric antigen receptor show potent activities against hepatocellular carcinoma.
    Wang P; Qin W; Liu T; Jiang D; Cui L; Liu X; Fang Y; Tang X; Jin H; Qian Q
    Immunobiology; 2020 Jan; 225(1):151850. PubMed ID: 31522780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-level genomic integration, epigenetic changes, and expression of sleeping beauty transgene.
    Zhu J; Park CW; Sjeklocha L; Kren BT; Steer CJ
    Biochemistry; 2010 Feb; 49(7):1507-21. PubMed ID: 20041635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new approach to CAR T-cell gene engineering and cultivation using piggyBac transposon in the presence of IL-4, IL-7 and IL-21.
    Ptáčková P; Musil J; Štach M; Lesný P; Němečková Š; Král V; Fábry M; Otáhal P
    Cytotherapy; 2018 Apr; 20(4):507-520. PubMed ID: 29475789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible Transgene Expression in Human iPS Cells Using Versatile All-in-One piggyBac Transposons.
    Kim SI; Oceguera-Yanez F; Sakurai C; Nakagawa M; Yamanaka S; Woltjen K
    Methods Mol Biol; 2016; 1357():111-31. PubMed ID: 26025620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplexed transposon-mediated stable gene transfer in human cells.
    Kahlig KM; Saridey SK; Kaja A; Daniels MA; George AL; Wilson MH
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1343-8. PubMed ID: 20080581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PiggyBac transposon-based inducible gene expression in vivo after somatic cell gene transfer.
    Saridey SK; Liu L; Doherty JE; Kaja A; Galvan DL; Fletcher BS; Wilson MH
    Mol Ther; 2009 Dec; 17(12):2115-20. PubMed ID: 19809403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained high level transgene expression in mammalian cells mediated by the optimized
    Chen X; Cui J; Yan Z; Zhang H; Chen X; Wang N; Shah P; Deng F; Zhao C; Geng N; Li M; Denduluri SK; Haydon RC; Luu HH; Reid RR; He TC
    Genes Dis; 2015 Mar; 2(1):96-105. PubMed ID: 25815368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PiggyBac transposon-mediated gene transfer in human cells.
    Wilson MH; Coates CJ; George AL
    Mol Ther; 2007 Jan; 15(1):139-45. PubMed ID: 17164785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multigene expression in stable CHO cell pools generated with the piggyBac transposon system.
    Balasubramanian S; Wurm FM; Hacker DL
    Biotechnol Prog; 2016 Sep; 32(5):1308-1317. PubMed ID: 27302570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of non-viral, transgene-free hepatocyte like cells with piggyBac transposon.
    Katayama H; Yasuchika K; Miyauchi Y; Kojima H; Yamaoka R; Kawai T; Yukie Yoshitoshi E; Ogiso S; Kita S; Yasuda K; Sasaki N; Fukumitsu K; Komori J; Ishii T; Uemoto S
    Sci Rep; 2017 Mar; 7():44498. PubMed ID: 28295042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of constitutive promoters for piggyBac transposon-mediated stable transgene expression in mesenchymal stem cells (MSCs).
    Wen S; Zhang H; Li Y; Wang N; Zhang W; Yang K; Wu N; Chen X; Deng F; Liao Z; Zhang J; Zhang Q; Yan Z; Liu W; Zhang Z; Ye J; Deng Y; Zhou G; Luu HH; Haydon RC; Shi LL; He TC; Wei G
    PLoS One; 2014; 9(4):e94397. PubMed ID: 24714676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Tol2 transposon system mediates the genetic engineering of T-cells with CD19-specific chimeric antigen receptors for B-cell malignancies.
    Tsukahara T; Iwase N; Kawakami K; Iwasaki M; Yamamoto C; Ohmine K; Uchibori R; Teruya T; Ido H; Saga Y; Urabe M; Mizukami H; Kume A; Nakamura M; Brentjens R; Ozawa K
    Gene Ther; 2015 Feb; 22(2):209-15. PubMed ID: 25427612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.